COMETRIQ (Exelixis, Inc.)
Welcome to the PulseAid listing for the COMETRIQ drug offered from Exelixis, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Exelixis, Inc. |
NON-PROPRIETARY NAME: | cabozantinib |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-11-29 |
END MARKETING DATE: | 0000-00-00 |
COMETRIQ HUMAN PRESCRIPTION DRUG Details:
Item Description | COMETRIQ from Exelixis, Inc. |
LABELER NAME: | Exelixis, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2012-11-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42388-011_fc9853b8-b4a4-42b7-915f-a97a80586080 |
PRODUCT NDC: | 42388-011 |
APPLICATION NUMBER: | NDA203756 |